Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Rodriguez

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Environmental Microbiology|June 5, 2019
Phylogenomics of Enterococcus faecalis from wild birds: new insights into host-associated differences in core and accessory genomes of the speciesRicardo León-Sampedro, Rosa Del Campo, Mercedes Rodriguez-Baños, et al.
British Journal of Haematology|May 18, 2016
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapyCarmen Martínez, Antonio Díaz-López, Mercedes Rodriguez-Calvillo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 14, 2024
Utility of endoscopic ultrasound-guided fine needle aspiration for genetic analysis in pancreatic ductal adenocarcinomaIrene Ligato, Ana Garcia Garcia de Paredes, Sergio Lopez Duran, et al.
NEJM Evidence|February 6, 2024
<i>Nab</i>-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic CancerAlfredo Carrato, Roberto Pazo-Cid, Teresa Macarulla, et al.
BMC Cancer|September 19, 2024
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocolAlfredo Budillon, Alessandra Leone, Eugenia Passaro, et al.
The Journal of Clinical Investigation|June 17, 2010
Monocytic suppressive cells mediate cardiovascular transplantation tolerance in miceMercedes Rodriguez Garcia, Levi Ledgerwood, Yu Yang, et al.
Cancers|April 30, 2021
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular StudyElisa Conde, Julie Earl, Lorena Crespo-Toro, et al.
The Lancet. Oncology|June 4, 2024
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 studyJean-Luc Van Laethem, Ivan Borbath, Hans Prenen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2019
Mobility in osteogenesis imperfecta: a multicenter North American studyKaren M Kruger, Angela Caudill, Mercedes Rodriguez Celin, et al.
Journal of Neurotrauma|January 30, 2021
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical TrialOlga Brawman-Mintzer, X Charlene Tang, Marcel Bizien, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Environmental Microbiology|June 5, 2019
Phylogenomics of Enterococcus faecalis from wild birds: new insights into host-associated differences in core and accessory genomes of the speciesRicardo León-Sampedro, Rosa Del Campo, Mercedes Rodriguez-Baños, et al.
British Journal of Haematology|May 18, 2016
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapyCarmen Martínez, Antonio Díaz-López, Mercedes Rodriguez-Calvillo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 14, 2024
Utility of endoscopic ultrasound-guided fine needle aspiration for genetic analysis in pancreatic ductal adenocarcinomaIrene Ligato, Ana Garcia Garcia de Paredes, Sergio Lopez Duran, et al.
NEJM Evidence|February 6, 2024
<i>Nab</i>-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic CancerAlfredo Carrato, Roberto Pazo-Cid, Teresa Macarulla, et al.
BMC Cancer|September 19, 2024
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocolAlfredo Budillon, Alessandra Leone, Eugenia Passaro, et al.
The Journal of Clinical Investigation|June 17, 2010
Monocytic suppressive cells mediate cardiovascular transplantation tolerance in miceMercedes Rodriguez Garcia, Levi Ledgerwood, Yu Yang, et al.
Cancers|April 30, 2021
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular StudyElisa Conde, Julie Earl, Lorena Crespo-Toro, et al.
The Lancet. Oncology|June 4, 2024
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 studyJean-Luc Van Laethem, Ivan Borbath, Hans Prenen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2019
Mobility in osteogenesis imperfecta: a multicenter North American studyKaren M Kruger, Angela Caudill, Mercedes Rodriguez Celin, et al.
Journal of Neurotrauma|January 30, 2021
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical TrialOlga Brawman-Mintzer, X Charlene Tang, Marcel Bizien, et al.
Pageof 10